BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 7191052)

  • 1. Sixty Years of Hemodynamic Pharmacology in Obstructive Hypertrophic Cardiomyopathy.
    Ommen SR
    N Engl J Med; 2024 May; 390(20):1914-1915. PubMed ID: 38739083
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
    Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
    Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.
    Griffiths BE; Hughes P; Dowdle R; Stephens MR
    Thorax; 1982 Sep; 37(9):711-2. PubMed ID: 6891504
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium blockers for cardiac disease: therapeutic implications.
    Dodek A; Ruedy J
    Can Med Assoc J; 1983 Apr; 128(8):911-5. PubMed ID: 6831336
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyopathy. Assessment with radionuclide cineangiography.
    Sugrue DD; McKenna WJ; Dickie S; Myers MJ; Lavender JP; Oakley CM; Goodwin JF
    Br Heart J; 1984 Dec; 52(6):602-9. PubMed ID: 6542420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?
    Goodwin JF
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):665-8. PubMed ID: 2908701
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical decisions in the management of the cardiomyopathies.
    Goodwin JF
    Drugs; 1989 Dec; 38(6):988-99. PubMed ID: 2693049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of a Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage.
    Komuro I; Kurabayashi M; Shibazaki Y; Takaku F; Yazaki Y
    J Clin Invest; 1989 Apr; 83(4):1102-8. PubMed ID: 2522936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nifedipine on left ventricular diastolic function in hypertension; echo Doppler study.
    Gambelli G; Amici E; Selvanetti A
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():951-5. PubMed ID: 2076406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
    Gwathmey JK; Warren SE; Briggs GM; Copelas L; Feldman MD; Phillips PJ; Callahan M; Schoen FJ; Grossman W; Morgan JP
    J Clin Invest; 1991 Mar; 87(3):1023-31. PubMed ID: 1999483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Left ventricular systolic and diastolic functions in hypertrophic cardiomyopathy: with special reference to clinical symptom and the effects of calcium blocking agent (nifedipine)].
    Yamakado T; Higashiyama S; Nakano T; Takezawa H
    J Cardiol Suppl; 1987; 16():53-63. PubMed ID: 3509683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic left ventricular function after nifedipine in healthy subjects and hypertrophic obstructive cardiomyopathy (CAPS) patients.
    Papadopoulos CL; Sakadamis G; Styliades J; Papayannis J; Giannacoulis J; Kokkas V; Muamani M; Cannonides J
    Acta Cardiol; 1988; 43(3):395-401. PubMed ID: 3261099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diastolic heart function. Pathophysiology, possibilities for evaluation and modifiability].
    Modersohn D; Walde T; Bruch L
    Z Arztl Fortbild (Jena); 1993 Feb; 87(2):111-21. PubMed ID: 8094928
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of calcium-entry blockade on left ventricular systolic and diastolic function.
    Walsh RA
    Circulation; 1987 Jun; 75(6 Pt 2):V43-55. PubMed ID: 3552316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
    N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
    Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.